ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/13 | 4,250 | 4,305 | 4,230 | 4,250 | +55 | +1.3% | 610,200 |
2021/08/12 | 4,175 | 4,250 | 4,170 | 4,195 | +55 | +1.3% | 614,600 |
2021/08/11 | 4,135 | 4,220 | 4,120 | 4,140 | +50 | +1.2% | 576,800 |
2021/08/10 | 3,970 | 4,185 | 3,910 | 4,090 | +55 | +1.4% | 937,400 |
2021/08/06 | 4,080 | 4,145 | 3,985 | 4,035 | -105 | -2.5% | 980,600 |
2021/08/05 | 4,200 | 4,260 | 4,135 | 4,140 | -65 | -1.5% | 815,900 |
2021/08/04 | 4,300 | 4,305 | 4,185 | 4,205 | -250 | -5.6% | 927,600 |
2021/08/03 | 4,490 | 4,510 | 4,430 | 4,455 | -95 | -2.1% | 592,700 |
2021/08/02 | 4,605 | 4,630 | 4,535 | 4,550 | +45 | +1% | 411,200 |
2021/07/30 | 4,550 | 4,580 | 4,480 | 4,505 | -65 | -1.4% | 655,800 |
2021/07/29 | 4,645 | 4,680 | 4,550 | 4,570 | -30 | -0.7% | 450,400 |
2021/07/28 | 4,675 | 4,730 | 4,580 | 4,600 | -200 | -4.2% | 605,100 |
2021/07/27 | 4,855 | 4,905 | 4,775 | 4,800 | +60 | +1.3% | 754,500 |
2021/07/26 | 4,755 | 4,795 | 4,730 | 4,740 | +80 | +1.7% | 318,800 |
2021/07/21 | 4,700 | 4,725 | 4,625 | 4,660 | +10 | +0.2% | 297,900 |
2021/07/20 | 4,695 | 4,710 | 4,630 | 4,650 | -70 | -1.5% | 285,100 |
2021/07/19 | 4,750 | 4,750 | 4,680 | 4,720 | -50 | -1% | 230,400 |
2021/07/16 | 4,725 | 4,815 | 4,710 | 4,770 | -5 | -0.1% | 252,400 |
2021/07/15 | 4,910 | 4,910 | 4,765 | 4,775 | -165 | -3.3% | 394,400 |
2021/07/14 | 4,850 | 4,950 | 4,850 | 4,940 | +95 | +2% | 343,400 |
2021/07/13 | 4,875 | 4,910 | 4,805 | 4,845 | -65 | -1.3% | 329,300 |
2021/07/12 | 4,935 | 4,945 | 4,860 | 4,910 | +75 | +1.6% | 318,600 |
2021/07/09 | 4,840 | 4,885 | 4,780 | 4,835 | -50 | -1% | 574,400 |
2021/07/08 | 5,000 | 5,030 | 4,880 | 4,885 | -165 | -3.3% | 456,500 |
2021/07/07 | 5,070 | 5,100 | 5,010 | 5,050 | -60 | -1.2% | 279,300 |
2021/07/06 | 5,210 | 5,230 | 5,070 | 5,110 | -130 | -2.5% | 271,000 |
2021/07/05 | 5,220 | 5,310 | 5,220 | 5,240 | -30 | -0.6% | 169,200 |
2021/07/02 | 5,390 | 5,430 | 5,240 | 5,270 | -110 | -2% | 312,800 |
2021/07/01 | 5,490 | 5,500 | 5,350 | 5,380 | -70 | -1.3% | 236,900 |
2021/06/30 | 5,380 | 5,510 | 5,380 | 5,450 | +150 | +2.8% | 373,700 |
2021/06/29 | 5,220 | 5,320 | 5,210 | 5,300 | +50 | +1% | 432,800 |
2021/06/28 | 5,300 | 5,350 | 5,200 | 5,250 | -150 | -2.8% | 412,000 |
2021/06/25 | 5,440 | 5,440 | 5,360 | 5,400 | +20 | +0.4% | 166,200 |
2021/06/24 | 5,450 | 5,490 | 5,360 | 5,380 | -120 | -2.2% | 295,700 |
2021/06/23 | 5,470 | 5,560 | 5,460 | 5,500 | -20 | -0.4% | 267,700 |
2021/06/22 | 5,400 | 5,530 | 5,380 | 5,520 | +220 | +4.2% | 418,300 |
2021/06/21 | 5,360 | 5,370 | 5,270 | 5,300 | -100 | -1.9% | 290,000 |
2021/06/18 | 5,470 | 5,470 | 5,380 | 5,400 | +30 | +0.6% | 423,000 |
2021/06/17 | 5,380 | 5,410 | 5,320 | 5,370 | -20 | -0.4% | 290,000 |
2021/06/16 | 5,260 | 5,440 | 5,260 | 5,390 | +130 | +2.5% | 493,300 |
2021/06/15 | 5,140 | 5,270 | 5,140 | 5,260 | +130 | +2.5% | 408,600 |
2021/06/14 | 5,080 | 5,140 | 5,020 | 5,130 | +70 | +1.4% | 219,500 |
2021/06/11 | 4,995 | 5,100 | 4,980 | 5,060 | +135 | +2.7% | 392,900 |
2021/06/10 | 4,970 | 4,990 | 4,895 | 4,925 | -20 | -0.4% | 210,000 |
2021/06/09 | 5,020 | 5,030 | 4,935 | 4,945 | -85 | -1.7% | 288,100 |
2021/06/08 | 4,930 | 5,060 | 4,930 | 5,030 | +155 | +3.2% | 361,000 |
2021/06/07 | 4,840 | 4,885 | 4,770 | 4,875 | +110 | +2.3% | 277,900 |
2021/06/04 | 4,850 | 4,850 | 4,750 | 4,765 | -125 | -2.6% | 290,700 |
2021/06/03 | 4,980 | 5,010 | 4,880 | 4,890 | -70 | -1.4% | 290,500 |
2021/06/02 | 5,000 | 5,090 | 4,940 | 4,960 | +60 | +1.2% | 419,500 |
901~
950
件表示中 / 2897件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 181,500円 | +5.0% | +1.5% | 0.00% | 15.58倍 | 4.14倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 356,700円 | +7.9% | +8.9% | 3.48% | 7.63倍 | 1.02倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 60,800円 | +21.1% | - | 0.00% | 15.10倍 | 2.12倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 402,000円 | +30.5% | +111.0% | 4.73% | 11.33倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 359,500円 | +14.5% | -2.3% | 2.50% | 13.15倍 | 0.70倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム